[1]
G. Andhuvan, “A Study on Safety and Efficacy of Sodium-glucose Cotransporter-2 Inhibitors as Adjuvant to Insulin Add-on Therapy in Uncontrolled Type 2 Diabetic Patients”, AJP, vol. 12, no. 03, Nov. 2018.